Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1050825]Researchers: Prof Shudong Wang (Principal investigator)
Brief description Cancer is a leading cause of death worldwide. In 2010 an estimated 43,000 Australians died from cancer and 114,000 new cases were diagnosed. New treatments are urgently needed. Protein kinases Mnks promote human tumourogenesis, but they are dispensable for normal tissue development. Inhibition of Mnks’ activity therefore presents an excellent strategy for effective and nontoxic cancer therapy. This project aims to develop Mnk inhibitor drug candidates for potential clinic application.
Funding Amount $AUD 505,894.33
Funding Scheme Project Grants
Notes New Investigator Grant
- nhmrc : 1050825
- PURL : https://purl.org/au-research/grants/nhmrc/1050825
